CANDY FLIP

CANDY FLIP is a term commonly used to describe the combination of LSD (lysergic acid diethylamide) and MDMA (3,4-methylenedioxymethamphetamine). Unlike a standardized pharmaceutical product, the term “candy flip” describes a pattern of combining two different psychoactive substances.

LSD is a powerful psychedelic that primarily affects serotonin receptors and can substantially alter perception, thought, mood, sensory processing, and one’s experience of time and surroundings.

MDMA is a psychoactive stimulant and entactogen that affects serotonin, dopamine, and norepinephrine systems. It can produce changes in mood, emotional processing, sociability, sensory experience, heart rate, blood pressure, and body temperature.

Because CANDY FLIP refers to a combination rather than a single standardized chemical compound, its effects and risks can vary considerably.

The name itself does not establish the identity, concentration, purity, or safety of any particular product or sample.

Understanding the Term

“Candy flipping” is informal terminology rather than a scientific or medical classification.

The term generally refers to the combined use of LSD and MDMA. However, products or substances marketed using the name CANDY FLIP may not necessarily contain both substances.

A name, logo, package, tablet design, or seller description cannot reliably establish chemical composition.

For scientifically accurate documentation, the actual contents of a sample must be determined through appropriate analytical testing.